SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | REGENERON PHARMACEUTICALS INC | 4,327,689 | 4.1% | EDGAR |
SC 13G/A | 2018-01-29 | BlackRock Inc. | REGENERON PHARMACEUTICALS INC | 6,011,755 | 5.7% | EDGAR |
SC 13D/A | 2018-01-09 | Sanofi | REGENERON PHARMACEUTICALS INC | 23,880,537 | 22.6% | EDGAR |
SC 13G/A | 2017-02-14 | FMR LLC | REGENERON PHARMACEUTICALS INC | 7,824,325 | 7.6% | EDGAR |
SC 13G/A | 2017-02-13 | Capital World Investors | REGENERON PHARMACEUTICALS INC | 7,759,325 | 7.4% | EDGAR |
SC 13G | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | REGENERON PHARMACEUTICALS INC | 5,688,709 | 5.5% | EDGAR |
SC 13D/A | 2017-01-31 | Sanofi | REGENERON PHARMACEUTICALS INC | 23,505,694 | 22.7% | EDGAR |
SC 13G/A | 2017-01-25 | BlackRock Inc. | REGENERON PHARMACEUTICALS INC | 6,095,983 | 5.9% | EDGAR |
SC 13G | 2016-05-11 | REGENERON PHARMACEUTICALS INC | Intellia Therapeutics, Inc. | 2,777,777 | 7.7% | EDGAR |
SC 13G/A | 2016-02-16 | SANDS CAPITAL MANAGEMENT, LLC | REGENERON PHARMACEUTICALS INC | 3,698,553 | 3.6% | EDGAR |
SC 13G/A | 2016-02-16 | Capital World Investors | REGENERON PHARMACEUTICALS INC | 6,804,465 | 6.6% | EDGAR |
SC 13G/A | 2016-02-12 | FMR LLC | REGENERON PHARMACEUTICALS INC | 6,223,092 | 6.1% | EDGAR |
SC 13G/A | 2016-02-11 | WELLINGTON MANAGEMENT GROUP LLP | REGENERON PHARMACEUTICALS INC | 4,785,593 | 4.7% | EDGAR |
SC 13G/A | 2016-02-10 | BlackRock Inc. | REGENERON PHARMACEUTICALS INC | 5,382,473 | 5.3% | EDGAR |
SC 13D/A | 2015-12-29 | Sanofi | REGENERON PHARMACEUTICALS INC | 23,108,570 | 22.6% | EDGAR |
SC 13G/A | 2015-02-13 | FMR LLC | REGENERON PHARMACEUTICALS INC | 6,687,091 | 6.7% | EDGAR |
SC 13G/A | 2015-02-13 | Capital World Investors | REGENERON PHARMACEUTICALS INC | 7,876,150 | 7.9% | EDGAR |
SC 13G/A | 2015-02-12 | PRICE T ROWE ASSOCIATES INC /MD/ | REGENERON PHARMACEUTICALS INC | 3,939,854 | 3.9% | EDGAR |
SC 13G | 2015-02-12 | WELLINGTON MANAGEMENT GROUP LLP | REGENERON PHARMACEUTICALS INC | 5,882,648 | 5.9% | EDGAR |
SC 13G | 2015-02-12 | SANDS CAPITAL MANAGEMENT, LLC | REGENERON PHARMACEUTICALS INC | 4,986,177 | 5.0% | EDGAR |